A reevaluation of glaucoma management.
D000086:Acetazolamide / Q000627:therapeutic use; D002386:Cataract / Q000209:etiology; D003365:Costs and Cost Analysis; D064420:Drug-Related Side Effects and Adverse Reactions; D009877:Endophthalmitis / Q000209:etiology; D004837:Epinephrine / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D010862:Pilocarpine / Q000627:therapeutic use; D011183:Postoperative Complications; D013618:Tachyphylaxis; D013997:Time Factors; D013999:Timolol / Q000627:therapeutic use; D014129:Trabecular Meshwork / Q000187:drug effects / Q000601:surgery; D014792:Visual Acuity
D010862:Pilocarpine; D013999:Timolol; D000086:Acetazolamide; D004837:Epinephrine